Dr. Wolfgang Albrecht has been working in a mid-sized pharmaceutical company for close to 24 years with many years of experience in DMPK and as Department Head for drug discovery, early drug development and chemical research. Wolfgang became the Founding CEO/Managing Director of HepaRegeniX in early 2017 before being appointed as COO in October 2019. Wolfgang is a biotechnologist by training with a Dr.-Ing. from the Technical University of Berlin.